Protagonist Therapeutics, Inc. (PTGX)

NASDAQ: PTGX · IEX Real-Time Price · USD

26.09

+0.55 (2.15%)

At close: May 3, 2024, 4:00 PM

25.58

-0.51 (-1.95%)

After-hours: May 3, 2024, 5:31 PM EDT

Protagonist Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016
Market Capitalization	1,520	1,323	537	1,632	771	192	163	426	368
Market Cap Growth	-	146.40%	-67.12%	111.64%	302.10%	17.84%	-61.79%	15.90%	-
Enterprise Value	1,180	982	303	1,311	471	76	34	282	290
PE Ratio	-16.75	-16.75	-4.21	-13.00	-11.66	-2.48	-4.18	-11.53	-9.74
PS Ratio	25.34	22.04	20.19	59.67	26.94	830.33	5.26	21.23	-
PB Ratio	4.52	3.93	2.49	5.44	2.76	2.40	1.45	3.53	4.20
P/FCF Ratio	-18.67	-18.67	-4.93	-14.98	-10.57	-4.51	-3.23	132.87	-12.12
P/OCF Ratio	-18.83	-18.83	-4.96	-15.13	-10.64	-4.62	-3.26	110.01	-12.26
EV/Sales Ratio	19.67	16.37	11.40	47.93	16.47	328.09	1.10	14.05	-
EV/EBITDA Ratio	-12.98	-12.98	-2.44	-10.68	-7.66	-1.01	-0.87	-7.71	-7.75
EV/EBIT Ratio	-12.44	-12.44	-2.38	-10.44	-7.34	-0.98	-0.85	-7.63	-7.68
EV/FCF Ratio	-13.86	-13.86	-2.78	-12.03	-6.46	-1.78	-0.67	87.95	-9.56
Debt / Equity Ratio	0.00	0.00	0.02	0.02	0.02	0.21	-	-	-
Debt / EBITDA Ratio	-0.02	-0.02	-0.03	-0.05	-0.10	-0.23	-	-	-
Debt / FCF Ratio	-0.02	-0.02	-0.03	-0.05	-0.08	-0.40	-	-	-
Quick Ratio	16.53	16.53	7.61	7.46	7.66	3.95	5.10	3.43	12.06
Current Ratio	16.71	16.71	7.80	7.74	7.84	4.10	5.26	3.55	12.94
Asset Turnover	0.19	0.19	0.09	0.08	0.13	0.00	0.22	0.19	0
Interest Coverage	-	-	-	-	-107.44	-459.82	-	-	-
Return on Equity (ROE)	-27.50%	-27.50%	-49.50%	-40.30%	-38.90%	-85.70%	-33.90%	-47.00%	-151.10%
Return on Assets (ROA)	-25.30%	-25.30%	-42.90%	-35.30%	-29.30%	-52.30%	-27.10%	-34.60%	-59.60%
Return on Capital (ROIC)	-27.72%	-27.72%	-59.92%	-41.14%	-22.59%	-83.03%	-37.57%	-31.42%	-37.35%
Earnings Yield	-5.19%	-5.97%	-23.73%	-7.69%	-8.58%	-40.24%	-23.91%	-8.68%	-10.27%
FCF Yield	-4.66%	-5.36%	-20.29%	-6.68%	-9.46%	-22.15%	-30.98%	0.75%	-8.25%
Buyback Yield / Dilution	-15.74%	-15.74%	-5.87%	-34.67%	-32.84%	-15.78%	-26.39%	-172.15%	-2482.98%
Total Shareholder Return	-15.74%	-15.74%	-5.87%	-34.67%	-32.84%	-15.78%	-26.39%	-172.15%	-2482.98%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).